Form 4 Filing for Adaptive Biotechnologies Corp

This filing details stock transactions by LO FRANCIS, Chief People Officer of Adaptive Biotechnologies Corp, on October 1, 2026. The transactions were executed under a Rule 10b5-1 trading plan. Francis Lo acquired shares through the exercise of stock options at varying prices and also disposed of shares. Specifically, 8,038 shares were acquired at $8.46, 9,377 at $3.99, and another 9,377 at $8.12. Concurrently, 8,094 shares were sold at a weighted average price of $27.52 (ranging from $27.22 to $28.22) and 18,698 shares were sold at a weighted average price of $28.61 (ranging from $28.33 to $29.00). Following these transactions, Francis Lo